Request a copy

Full Text

• (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med , American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference; 20:864-874.
• Bone R.C. (1992) Toward an epidemiology and natural history of SIRS (systemic inflammatory response syndrome). JAMA 268:3452-3455.
• Bone R.C. (1993) Gram-negative sepsis: a dilemma of modern medicine. Clin Mibrobiol Rev 6:57-68.
• Matuschak G., Rinaldo J. (1988) Organ interactions in the ARDS during sepsis. Role of the liver in host defense. Chest 94:401-406.
• Welbourn C.R.B., Young Y. (1992) Endotoxin, septic shock and acute lung injury: neutrophils, macrophages and inflammatory mediators. Br J Surg 79:998-1003.
• Parrilo J.E. (1993) Pathogenetic mechanisms of septic shock. N Engl J Med 328:1471-1477.
• Cipolle M.D., Pasquale M.D., Cerra F.B. (1993) Secondary organ dysfunction. From clinical perspectives to molecular mediators. Crit Care Clin 9:261-298.
• Strieter R.M., Lynch J.P., Basha M.A., Standiford T.J., Kasahara K., Kunkel S.L. (1990) Host responses in mediating sepsis and adult respiratory distress syndrome. Semin Respir Infect 5:233-247.
• Manthous C.A., Hall J.B., Sael R.W. (1993) Endotoxin in human disease. Part 1. Biochemistry, assay and possible role in diverse disease states. Chest 104:1572-1581.
• Bone R.C. (1994) Gram-positive organisms and sepsis. Arch Intern Med 154:2634.
• Gardinali M., Padalino P., Vesconi S. (1992) Complement activation and polymorphonuclear neutrophil leukocyte elastase in sepsis. Correlation with severity of disease. Arch Surg 127(10):1219-1224.
• Monick M., Glazier J., Hunninghake G.W. (1987) Human alveolar macrophages suppress interleukin-1 (IL-1) activity via the secretion of prostaglandin E2. Am Rev Respir Dis 135:72-77.
• Manthous C.A., Hall J.B., Sael R.W. (1993) Endotoxin in human disease. Part 2. Biologic effects and clinical evaluations of antiendotoxin therapies. Chest 104:1872-1881.
• Bruin K.F., von der Möhlen M.A.M., van Deventer S.J.H. (1994) Endotoxemia and sepsis: important roles for lipopolysaccharides, binding proteins and CD 14 in endotoxin signal transduction. Sepsis. Current perspectives in pathophysiology and therapy , K., Reinhart, K., Eyrich, C., Sprung, Springer, Berlin; 53-60.
• Kirikae T., Lei M.G., Chen T.Y., Morrison D.C. (1994) Interactions of endotoxin with membranes and membrane receptors. Endotoxin and the lungs , K., Brigham, Marcel Dekker, New York; 21-44.
• Martin T.R., Tobias P.S., Mathison J.C., Ulevitch R.J. (1994) Interactions between endotoxin and endotoxin-binding protein. Endotoxin and the lungs , K., Brigham, Marcel Dekker, New York; 45-67.
• Schumann R.R., Lamping N., Kirschning C., Knopf H.P., Hoess A., Hermann F. (1994) Lipopolysaccharide binding proteins: its role and therapeutical potential in inflammation and sepsis. Biochem Soc Trans 22:80-83.
• Tracey K.J., Cerami A. (1993) Tumor necrosis factor: an update review of its biology. Crit Care Med 21:S415-S422.
• Beutler B., Grau G.E. (1993) Tumor necrosis factor in the pathogenesis of infectious disease. Crit Care Med 21:S423-S435.
• Dunn D.L. (1991) Role of endotoxin and host cytokines in septic shock. Chest 100:164S-168S.
• Ghosh S., Latimer R., Gray B.M., Harwood R.J., Oduro A. (1993) Endotoxin-induced organ injury. Crit Care Med 21:S19-S24.
• Marks J.D., Marks C.B., Luce J.M. (1990) Plasma tumor necrosis factor in patients with septic shock. Am Rev Respir Dis 141:94-97.
• Damas P., Reuter A., Gysen P., Demonty J., Lamy M., Franchimont P. (1989) Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit Care Med 17:975-978.
• Dinarello C.A., Gelfand J.A., Wolff S.M. (1993) Anticytokine strategies in the treatment of the systemic inflammatory response syndrome. JAMA 269:1829-1835.
• de Wall J., Malefyt R., Abra J., Bennett B., Figdor C.C., de Vries J.E. (1991) Interleukin-10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulary role for IL-10 produced by monocytes. J Exp Med 174:1209-1220.
• Marchant A., Devière J., Byl B., De Groote D., Vincent J.L., Goldman M. (1994) Interleukin-10 production during septicaemia. Lancet 343:707-708.
• Exley A.R., Cohen J., Buurman W. (1990) Monoclonal antibody to TNF in severe septic shock. Lancet 335:1275-1277.
• Fisher C.J., Opal S.M., Dhainaut J.F. (1993) Influence of an anti-tumor necrosis monoclonal antibody on cytokine levels in patients with sepsis. Crit Care Med 21:318-327.
• Fisher C.J., Slotman G.J., Opal S.M. (1994) Ihitial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of septic syndrome: a randomized, open-label, placebo-controlled, multicenter trial. Crit Care Med 22:12-21.
• Mantovani A., Bussolino F., Dejana E. (1992) Cytokines regulation of endothelial cell function. FASEB J 6:2591-2599.
• Osborn L. (1990) Leukocyte adhesion to endothelium in inflammation. Cells 62:3-6.
• Gee M.H., Albertine K.H. (1993) Neutrophil-endothelial cell interactions in the lung. Ann Rev Physiol 55:227-248.
• Malik A.B. (1993) Endothelial cell interactions and integrins. New Horizons 1:37-51.
• Ada D.H., Shaw S. (1994) Leucocyte-endothelial interactions and regulation of leucocyte migration. Lancet 343:831-836.
• Kilbourn R.G., Belloni P. (1990) Endothelial cell production of nitrogen oxides in response to interferon gamma in combination with tumor necrosis factor, interleukin-1, or endotoxin. J Nath Cancer Inst 82:772-776.
• Vallance P., Moncada S. (1993) Role of endogenous nitric oxide in septic shock. New Horizons 1:77-86.
• Moncada S., Palmer R., Higgs E. (1991) Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 43:109-142.
• Ochoa J.B., Udekura O.A., Billiar T.R. (1991) Nitrogen oxide levels in patients following trauma and during sepsis. Ann Surg 214:621-626.
• Lorente J.A., Landin L., De Pablo R. (1993) L-arginine pathway in the sepsis syndrome. Crit Care Med 21:1287-1295.
• Anggard E. (1994) Nitric oxide: mediator, murderer, and medicine. Lancet 343:1199-1206.
• Freeman B. (1994) Free radical chemistry of nitric oxide. Looking at the dark side. Chest 105:79S-84S.
• Klebanoff S.J. (1988) Phagocytic cells: products of oxygen metabolism. Inflammation: basic principles and clinical correlates , J.I., Gallin, J.M., Goldstein, R., Snyderman, Raven Press, New York; 391-444.
• Weiss S.J. (1989) Tissue destruction by neutrophils. N Engl J Med 320:365-375.
• Zimmerman G.A., Prescott S.M., McIntyre T.M. (1992) Endothelial cell interactions with granulocytes: tethering and signaling molecules. Immunol Today 13:93-99.
• Ward P.A. (1991) Mechanisms of endothelial cell killing by H2O2 or products of activated neutrophils. The American Journal of Medicine 91:89S-94S.
• Zimmerman J.J. (1992) Oxyradical pathogenesis in sepsis. Mediators of sepsis. Update in intensive care and emergency medicine, vol 16 , M., Lamy, L.G., Thys, Springer, Berlin; 136-151.
• Kretzschmar M. (1994) Role of oxygen free radicals in the pathophysiology of sepsis. Sepsis. Current perspectives in pathophysiology and therapy , K., Reinhart, K., Eyrich, C., Sprung, Springer, Berlin; 122-135.
• Goode H.F., Webster N.R. (1993) Free radicals and antioxidants in sepsis. Crit Care Med 21:1770-1776.
• Nahum A., Chamberlin W., Sznajder J.I. (1991) Differential activation of mixed venous and arterial neutrophils in patients with sepsis syndrome and acute lung injury. Am Rev Respir Dis 143:1083-1087.
• Sznajder J.L., Fraiman A., Hall J.B. (1989) Increased hydrogen peroxide in the expired breath of patients with acute hypoxemia respiratory failure. Chest 96:606-612.
• Bertrand Y., Pincemail J., Hannique G. (1989) Differences in tocopherol-lipid ratio in ARDS and no ARDS patients. Intensive Care Med 15:87-93.
• Pacht E.R., Timerman A.P., Lykens M.G., Merola A.J. (1991) Deficiency of alveolar fluid glutathione in patients with sepsis and the adult respiratory distress syndrome. Chest 100:1397-1403.
• Leff J.A., Parsons P.E., Day C.E. (1993) Serum antioxidants as predictors of adult respiratory distress syndrome in patients with sepsis. Lancet 341:777-780.
• Levi M., Ten Cate H., van der Poll T., van Deventer S.J.H. (1993) Pathogenesis of disseminated intravascular coagulation in sepsis. JAMA 270:975-979.
• Koltai M., Hosford D., Braquet P. (1993) Platelet-activating factor in septic shock. New Horizons 1:87-95.